With 128 listings on European exchanges raising EUR31.3bn in the year to July 2015, the continent’s IPO market is in robust health despite economic and political hurdles, according to a new report from the Mergermarket Group.
Deals still in the pipeline could see this year beat 2014’s bumper EUR42bn issuance.
Banks have pointed to positive aftermarket results vs 2014, with all top 10 European listings still in green territory one month after listing.
If markets stabilise post the China sell-off, some large deals are in prospect for the remainder of 2015, with Poste Italiane and ABM AMRO looking to list before year-end.
Pharma, medical and biotech has been the most active sector to date, with 25 listings, followed by technology, media & telecoms and financial services, each of which has seem 21 IPOs in Europe.
